carteolol has been researched along with Coronary Heart Disease in 7 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In 17 patients with coronary heart disease the influence of the beta-blocking agent 5-(3-tert-butylamino-2-hydroxy-propoxy)-3, 4-dihydro-2(1H)-quinolinone-hydrochloride) (carteolol hydrochloride, Endak, Endak mite) (0." | 7.66 | [Hemodynamic studies at rest and under stress in patients with coronary heart disease after administration of carteolol]. ( Dundalek, E; Griebenow, R; Saborowski, F; Sy, M, 1983) |
| "Penbutolol and carteolol are two new long acting, nonselective beta-adrenergic blockers which have been approved for the treatment of systemic hypertension." | 4.78 | Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonism. ( Covey, S; Frishman, WH, 1990) |
| "Publications dealing with the results of treating coronary heart disease patients with 5-(3-tert-butylamino-2-hydroxy-propoxy)-3, 4-dihydro-2(1H)-quinolinone hydrochloride (carteolol hydrochloride, Endak, Endak mite) are reviewed." | 3.66 | [Clinical experiences in patients with coronary heart disease and angina pectoris]. ( Sölter, H, 1983) |
| "In 17 patients with coronary heart disease the influence of the beta-blocking agent 5-(3-tert-butylamino-2-hydroxy-propoxy)-3, 4-dihydro-2(1H)-quinolinone-hydrochloride) (carteolol hydrochloride, Endak, Endak mite) (0." | 3.66 | [Hemodynamic studies at rest and under stress in patients with coronary heart disease after administration of carteolol]. ( Dundalek, E; Griebenow, R; Saborowski, F; Sy, M, 1983) |
| " The dose-response relation and duration of action of the beta-blocking agent 5-(3-tert-butylamino-2-hydroxy-propoxy)-3,4-dihydro-2(1H)-quinolinone hydrochloride (carteolol hydrochloride, Endak, Endak mite) were investigated by means of exercise testing under randomized, double-blind conditions in two groups of healthy probands (n = 9 and n = 9, respectively)." | 2.65 | [Heart rate behavior and the ischemic ST-segment under carteolol hydrochloride. Dose-response relationship and duration of effect]. ( Kaltenbach, M; Kober, G; Mikludy, R; Veidt, J, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sölter, H | 1 |
| Lorenz, D | 1 |
| Saborowski, F | 1 |
| Dundalek, E | 1 |
| Griebenow, R | 1 |
| Sy, M | 1 |
| Kober, G | 1 |
| Veidt, J | 1 |
| Mikludy, R | 1 |
| Kaltenbach, M | 1 |
| Ishida, M | 1 |
| Fujiwara, H | 1 |
| Kida, M | 1 |
| Kawai, C | 1 |
| Nakayama, S | 1 |
| Yamashita, S | 1 |
| Miura, I | 1 |
| Yabuuchi, Y | 1 |
| Frishman, WH | 1 |
| Covey, S | 1 |
| Lohmöller, G | 1 |
| Conca, W | 1 |
| Pötzl, C | 1 |
1 review available for carteolol and Coronary Heart Disease
| Article | Year |
|---|---|
Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonism.
Topics: Arrhythmias, Cardiac; Carteolol; Chemical Phenomena; Chemistry; Coronary Disease; Humans; Hypertensi | 1990 |
1 trial available for carteolol and Coronary Heart Disease
| Article | Year |
|---|---|
[Heart rate behavior and the ischemic ST-segment under carteolol hydrochloride. Dose-response relationship and duration of effect].
Topics: Adult; Angina Pectoris; Carteolol; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind | 1983 |
5 other studies available for carteolol and Coronary Heart Disease
| Article | Year |
|---|---|
[Clinical experiences in patients with coronary heart disease and angina pectoris].
Topics: Angina Pectoris; Blood Pressure; Carteolol; Coronary Disease; Electrocardiography; Female; Heart Rat | 1983 |
[Human pharmacology of carteolol].
Topics: Administration, Oral; Blood Platelets; Carteolol; Coronary Disease; Hemodynamics; Humans; Hypertensi | 1983 |
[Hemodynamic studies at rest and under stress in patients with coronary heart disease after administration of carteolol].
Topics: Adult; Aged; Blood Pressure; Carteolol; Coronary Disease; Female; Heart Rate; Hemodynamics; Humans; | 1983 |
Protective effect of carteolol, a beta-blocker, on myocardial cellular damage in ischemic and reperfused pig hearts: assessment with gated in vivo 31-phosphorus magnetic resonance spectroscopy and electron microscopy.
Topics: Adenosine Triphosphate; Animals; Carteolol; Coronary Disease; Hemodynamics; Hydrogen-Ion Concentrati | 1992 |
[Clinical significance of the ISA (intrinsic sympathomimetic activity) of the beta blocker carteolol].
Topics: Carteolol; Coronary Disease; Electrocardiography; Heart Rate; Humans; Hypertension; Propanolamines; | 1987 |